These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 35142071)

  • 61. Stimuli-Responsive Polymeric Nanoplatforms for Cancer Therapy.
    Chang D; Ma Y; Xu X; Xie J; Ju S
    Front Bioeng Biotechnol; 2021; 9():707319. PubMed ID: 34249894
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Recent advances of redox-responsive nanoplatforms for tumor theranostics.
    Chen M; Liu D; Liu F; Wu Y; Peng X; Song F
    J Control Release; 2021 Apr; 332():269-284. PubMed ID: 33662455
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Nanomaterials for alternative antibacterial therapy.
    Hemeg HA
    Int J Nanomedicine; 2017; 12():8211-8225. PubMed ID: 29184409
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Nano-sized platforms for vaginal drug delivery.
    El-Hammadi MM; Arias JL
    Curr Pharm Des; 2015; 21(12):1633-44. PubMed ID: 25354177
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Advances in cell penetrating peptides and their functionalization of polymeric nanoplatforms for drug delivery.
    Tian Y; Zhou S
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Mar; 13(2):e1668. PubMed ID: 32929866
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Controlled drug delivery systems in eradicating bacterial biofilm-associated infections.
    Liu Y; Li Y; Shi L
    J Control Release; 2021 Jan; 329():1102-1116. PubMed ID: 33098913
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Multifunctional nanoplatforms co-delivering combinatorial dual-drug for eliminating cancer multidrug resistance.
    Wei X; Song M; Li W; Huang J; Yang G; Wang Y
    Theranostics; 2021; 11(13):6334-6354. PubMed ID: 33995661
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Flexible nanoplatform facilitates antibacterial phototherapy by simultaneously enhancing photosensitizer permeation and relieving hypoxia in bacterial biofilms.
    Xu Q; Li Q; Ding M; Xiu W; Zhang B; Xue Y; Wang Q; Yang D; Dong H; Teng Z; Mou Y
    Acta Biomater; 2024 Jun; ():. PubMed ID: 38897337
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Advanced drug-delivery systems: mechanoresponsive nanoplatforms applicable in atherosclerosis management.
    Nurhidayah D; Maruf A; Zhang X; Liao X; Wu W; Wang G
    Nanomedicine (Lond); 2019 Dec; 14(23):3105-3122. PubMed ID: 31823682
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Recent advances in functionalized nanomaterials for the diagnosis and treatment of bacterial infections.
    Colino CI; Lanao JM; Gutierrez-Millan C
    Mater Sci Eng C Mater Biol Appl; 2021 Feb; 121():111843. PubMed ID: 33579480
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A pH/H
    Zhao Y; Zhu Y; Yang G; Xia L; Yu F; Chen C; Zhang L; Cao H
    J Mater Chem B; 2021 Jun; 9(25):5076-5082. PubMed ID: 34120155
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Endogenous stimuli-responsive nanoparticles for cancer therapy: From bench to bedside.
    Xie F; Wang M; Chen Q; Chi T; Zhu S; Wei P; Yang Y; Zhang L; Li X; Liao Z
    Pharmacol Res; 2022 Dec; 186():106522. PubMed ID: 36283629
    [TBL] [Abstract][Full Text] [Related]  

  • 73. pH-Responsive Polymer Nanoparticles for Drug Delivery.
    Deirram N; Zhang C; Kermaniyan SS; Johnston APR; Such GK
    Macromol Rapid Commun; 2019 May; 40(10):e1800917. PubMed ID: 30835923
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Nanosystems Based on Magnetic Nanoparticles and Thermo- or pH-Responsive Polymers: An Update and Future Perspectives.
    Mai BT; Fernandes S; Balakrishnan PB; Pellegrino T
    Acc Chem Res; 2018 May; 51(5):999-1013. PubMed ID: 29733199
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Chemoresponsive smart mesoporous silica systems - An emerging paradigm for cancer therapy.
    Murugan B; Krishnan UM
    Int J Pharm; 2018 Dec; 553(1-2):310-326. PubMed ID: 30316004
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Dual and multi-stimuli responsive polymeric nanoparticles for programmed site-specific drug delivery.
    Cheng R; Meng F; Deng C; Klok HA; Zhong Z
    Biomaterials; 2013 May; 34(14):3647-57. PubMed ID: 23415642
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Role of Nanocarrier Systems in Drug Delivery for Overcoming Multi-Drug Resistance in Bacteria.
    Qumsani AT
    Pak J Biol Sci; 2023 Feb; 26(3):131-137. PubMed ID: 37480270
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Emerging NIR light-responsive delivery systems based on lanthanide-doped upconverting nanoparticles.
    Le XT; Youn YS
    Arch Pharm Res; 2020 Jan; 43(1):134-152. PubMed ID: 31981073
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Enzyme responsive drug delivery systems in cancer treatment.
    Shahriari M; Zahiri M; Abnous K; Taghdisi SM; Ramezani M; Alibolandi M
    J Control Release; 2019 Aug; 308():172-189. PubMed ID: 31295542
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Stimuli-responsive mesoporous silica nanoparticles: A custom-tailored next generation approach in cargo delivery.
    Salve R; Kumar P; Ngamcherdtrakul W; Gajbhiye V; Yantasee W
    Mater Sci Eng C Mater Biol Appl; 2021 May; 124():112084. PubMed ID: 33947574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.